Point-of-care cellular and molecular pathology of breast tumors on a cell phone

Ended Grant Awarded Last action

Award ID
R01CA248491
Recipient
Awarding agency
Obligated
$2,933,598

Award facts

Assistance listing
93.394 Cancer Detection and Diagnosis Research
Completion date
Originally
Place of performance
North Carolina, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment -$3,481
Amendment $29,476
Amendment $530,552
Amendment $584,964
Amendment $49,222
Amendment $553,716
Amendment $607,659
Original award $581,490

Subawards

Subrecipient Amount Awarded
Kilimanjaro Christian Medical College Objectives – First, we will work with Duke investigators to continue our capacity building efforts at KCMC’s Pathology Laboratory. This will be… $78,551
Sloan-Kettering Institute For Cancer Research The proposed clinical research will be conducted in partnership with investigators from Duke University, North Carolina State University (NCSU), Memorial… $75,566
Biostealth Inc. Our role in this grant will be to provide input on the smaller scale manufacture of printed arrays on coated substrates taking place at Duke. $39,900
The Regents Of The University Of California. San Francisco The goal is to create a training set, by brightfield cellular microscopy scanning of archived UCSF FNA slides with known diahnosis on the D4scope. Those… $107,007
North Carolina State University The EpiView platform will be thoroughly tested by researchers in the clinical labs at Duke, who are not involved in smartphone device development. The… $282,282

Quick answers

Who received award R01CA248491?

R01CA248491 was awarded to Duke University by National Cancer Institute (National Institutes of Health) on February 26, 2020.

How much is award R01CA248491 worth?

$2,933,598 has been obligated on R01CA248491.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award